Literature DB >> 7548071

Domains of Mnt repressor: roles in tetramer formation, protein stability, and operator DNA binding.

C D Waldburger1, R T Sauer.   

Abstract

The Mnt repressor of bacteriophage P22 is a member of the ribbon-helix-helix family of gene regulatory proteins. Proteolytic cleavage of Mnt with chymotrypsin reveals that it consists of two structural domains. Both domains are required for high-affinity operator binding. The N domain (residues 1-51) is dimeric and binds weakly but specifically to operator DNA. The C domain (residues 52-82) forms an independent alpha-helical, tetramerization domain and, by itself, has no DNA-binding activity. In intact Mnt, the N and C domains help to stabilize each other against denaturation but appear to be linked rather flexibly. Assays of the half-operator affinities of Mnt and the isolated N domain indicate that binding to adjacent half-sites in the whole operator is stabilized by protein-protein contacts between N domains in addition to protein-protein contacts between C domains.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548071     DOI: 10.1021/bi00040a023

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Contributions of distinct quaternary contacts to cooperative operator binding by Mnt repressor.

Authors:  A Berggrun; R T Sauer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

2.  Non-independence of Mnt repressor-operator interaction determined by a new quantitative multiple fluorescence relative affinity (QuMFRA) assay.

Authors:  T K Man; G D Stormo
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

3.  AmrZ beta-sheet residues are essential for DNA binding and transcriptional control of Pseudomonas aeruginosa virulence genes.

Authors:  Elizabeth A Waligora; Deborah M Ramsey; Edward E Pryor; Haiping Lu; Thomas Hollis; Gina P Sloan; Rajendar Deora; Daniel J Wozniak
Journal:  J Bacteriol       Date:  2010-08-13       Impact factor: 3.490

4.  Binding of Pseudomonas aeruginosa AlgZ to sites upstream of the algZ promoter leads to repression of transcription.

Authors:  Deborah M Ramsey; Patricia J Baynham; Daniel J Wozniak
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

5.  NMR structure determination of the tetramerization domain of the Mnt repressor: An asymmetric alpha-helical assembly in slow exchange.

Authors:  I M Nooren; A V George; R Kaptein; R T Sauer; R Boelens
Journal:  J Biomol NMR       Date:  1999-09       Impact factor: 2.835

6.  The AlgT-dependent transcriptional regulator AmrZ (AlgZ) inhibits flagellum biosynthesis in mucoid, nonmotile Pseudomonas aeruginosa cystic fibrosis isolates.

Authors:  Anne H Tart; Michael J Blanks; Daniel J Wozniak
Journal:  J Bacteriol       Date:  2006-09       Impact factor: 3.490

7.  The Pseudomonas aeruginosa ribbon-helix-helix DNA-binding protein AlgZ (AmrZ) controls twitching motility and biogenesis of type IV pili.

Authors:  Patricia J Baynham; Deborah M Ramsey; Borys V Gvozdyev; Ellen M Cordonnier; Daniel J Wozniak
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

8.  Specificity of Mnt 'master residue' obtained from in vivo and in vitro selections.

Authors:  Fauzi S Silbaq; Steven E Ruttenberg; Gary D Stormo
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

9.  The Pseudomonas aeruginosa AmrZ C-terminal domain mediates tetramerization and is required for its activator and repressor functions.

Authors:  Binjie Xu; Yue Ju; Randal J Soukup; Deborah M Ramsey; Richard Fishel; Vicki H Wysocki; Daniel J Wozniak
Journal:  Environ Microbiol Rep       Date:  2015-12-21       Impact factor: 3.541

10.  The transcription factor AmrZ utilizes multiple DNA binding modes to recognize activator and repressor sequences of Pseudomonas aeruginosa virulence genes.

Authors:  Edward E Pryor; Elizabeth A Waligora; Binjie Xu; Sheri Dellos-Nolan; Daniel J Wozniak; Thomas Hollis
Journal:  PLoS Pathog       Date:  2012-04-12       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.